Madison, NJ, United States of America

Michelle Finnegan

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Michelle Finnegan: Innovator in Migraine Treatment

Introduction

Michelle Finnegan is a prominent inventor based in Madison, NJ, known for her significant contributions to the field of migraine treatment. With a total of seven patents to her name, she has made remarkable strides in developing effective therapies for individuals suffering from migraines.

Latest Patents

Among her latest patents, Michelle has focused on innovative methods for treating migraines. One of her notable patents involves the administration of atogepant or a pharmaceutically acceptable salt thereof for migraine treatment. Additionally, she has developed methods for the acute treatment of migraines with or without aura, specifically addressing the needs of patients with hepatic and renal impairments, as well as those taking certain medications.

Career Highlights

Michelle is currently employed at Allergan Pharmaceuticals International Limited, where she continues to advance her research and development efforts in migraine therapies. Her work has been instrumental in providing new options for patients who struggle with this debilitating condition.

Collaborations

Throughout her career, Michelle has collaborated with esteemed colleagues, including Joel M Trugman and Ramesh Boinpally. These partnerships have enhanced her research and contributed to the success of her innovative projects.

Conclusion

Michelle Finnegan stands out as a dedicated inventor in the pharmaceutical industry, particularly in the area of migraine treatment. Her innovative patents and collaborative efforts reflect her commitment to improving the lives of those affected by migraines.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…